Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

During the Trading Day
32.10 +0.28 / +0.88%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
32.10 0.00 / 0.00%
Volume: 2.4K
Health Technology
Medical Specialties

Company Description

Haemonetics Corp. is a global healthcare company, which provides innovative blood management solutions. Its products are divided into four categories: Plasma, Blood Center, Hospital, and Software Solutions. The Plasma product line includes plasma collection for fractionation. The Blood Center product line offers automated blood component and manual blood collection systems to blood collection centers. The Hospital product line provides a range of blood management solutions that significantly improve a hospital's system for acquiring blood. The Software Solutions product line offers solutions for blood drive planning, donor recruitment and retention, blood collection, component manufacturing and distribution, and transfusion management. Haemonetics was founded in 1971 and is headquartered in Braintree, MA.

Contact Information

Haemonetics Corp.
400 Wood Road
Braintree Massachusetts 02184-9114
P:(781) 848-7100
Investor Relations:
(781) 356-9402



Mutual fund holders59.64%
Other institutional47.19%
Individual stakeholders1.45%

Top Executives

Ronald G. GelbmanChief Executive Officer & Director
Kent J. DaviesChief Operating Officer
Christopher J. LindopChief Financial Officer & EVP-Business Development
Mark A. PopovskyChief Medical Officer & Vice President
Jonathan WhiteChief Science & Technology Officer